Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
- 23 March 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (75), 75ra25
- https://doi.org/10.1126/scitranslmed.3001875
Abstract
Breast cancer methylomes contribute to metastatic potential, modulate the metastasis transcriptome, and predict disease outcome.Keywords
This publication has 69 references indexed in Scilit:
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- The Epigenomics of CancerCell, 2007
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingNature Genetics, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJama-Journal Of The American Medical Association, 2006
- Control of Developmental Regulators by Polycomb in Human Embryonic Stem CellsCell, 2006
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000